Activin-A in Diabetes-Induced Cardiac Malformations in Embryos
Author:
- 28 May 2013
- journal article
- research article
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 98 (3) , 260-267
Abstract
BACKGROUND Heart defects are the most common abnormalities in infants of diabetic mothers. Cardiac malformation is associated with altered expression of the genes in the transforming growth factor β system, including inhibin βA, which forms activin‐A as a homodimer and functions through its effectors, Smad2 and Smad3. This study aimed to investigate the role of activin‐A in diabetes‐induced cardiac malformations. METHODS Diabetes mellitus in female mice (C57BL/6J) was induced via intravenous injection of streptozotocin. The expression of inhibin βA protein and phosphorylation of Smad2 and Smad3 in the embryonic hearts were examined using immunohistochemical, in situ proximity ligation, and immunoblot assays. Embryos and endocardial cushions of nondiabetic mice were cultured in a high concentration of glucose and treated with activin‐A. Mitosis was examined using BrdU incorporation assay and immunohistochemistry of phosphorylated histone H3. Migration of the endocardial cells was assessed using a collagen‐based cell migration assay. RESULTS The levels of inhibin βA expression and Smad2 and Smad3 activation were significantly reduced by maternal diabetes. Treatment with activin‐A significantly increased cell proliferation in the myocardium and migration of endocardial cells, compared with those in vehicle‐treated high glucose group, to the level in the euglycemic control group. CONCLUSIONS Maternal diabetes suppresses the expression of inhibin βA protein, as well as the activation of Smad2 and Smad3. Activin‐A rescues cell proliferation in the myocardium and migration of the endocardial cells suppressed by hyperglycemia. The activin‐Smad2/3 signaling system appears to play a role in cardiac malformation in diabetic embryopathy. Birth Defects Res (Part B) 98:260–267, 2013.Keywords
This publication has 49 references indexed in Scilit:
- Applications of small molecule BMP inhibitors in physiology and diseaseCytokine & Growth Factor Reviews, 2009
- Msx1 and Msx2are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardiumBMC Developmental Biology, 2008
- ROCK1 Expression is Regulated by TGFβ3 and ALK2 During Valvuloseptal Endocardial Cushion FormationThe Anatomical Record, 2008
- Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular developmentCardiovascular Diabetology, 2007
- TGFβ-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heartDevelopmental Dynamics, 2006
- Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formationDevelopmental Dynamics, 2005
- Rho-associated kinases play a role in endocardial cell differentiation and migrationDevelopmental Biology, 2004
- Elevated glucose inhibits VEGF-A–mediated endocardial cushion formationJournal of Cell Biology, 2003
- Rho‐associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferationDevelopmental Dynamics, 2002
- Functional analysis of activins during mammalian developmentNature, 1995